PROVECTUS BIOPHARMACEUTICALS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate
PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate of 3.86% for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate · last filed 2026-08-13
- PROVECTUS BIOPHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2026-03-31 was 3.86%.
- PROVECTUS BIOPHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2021 was 0.23%, a 0.00% change from fiscal 2020.
- PROVECTUS BIOPHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2020 was 0.23%.
- PROVECTUS BIOPHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2015 was 0.25%, a 0.00% change from fiscal 2014.
- PROVECTUS BIOPHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2014 was 0.25%, a 0.00% change from fiscal 2013.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | 3.86% 10-Q · filed 2026-08-13 | ||||
| 2026-03-31 | 3.86% 10-Q · filed 2026-05-14 | ||||
| 2025-09-30 | 3.86% 10-Q · filed 2025-11-13 | ||||
| 2025-06-30 | 3.86% 10-Q · filed 2025-08-14 | ||||
| 2021-12-31 | 0.23% 10-K · filed 2022-03-29 | ||||
| 2020-12-31 | 0.23% 10-K · filed 2021-03-02 | ||||
| 2015-12-31 | 0.25% 10-K · filed 2017-03-31 | ||||
| 2014-12-31 | 0.25% 10-K · filed 2017-03-31 | ||||
| 2013-12-31 | 0.25% 10-K · filed 2016-03-30 | ||||
| 2012-12-31 | 0.25% 10-K · filed 2015-03-12 | ||||
| 2011-12-31 | 0.25% 10-K · filed 2014-03-13 | 0.60% 10-K · filed 2013-03-14 | |||
| 2010-12-31 | 0.25% 10-K · filed 2013-03-14 |